Abstract
Background and Objective
The therapeutic effects of cholinergic antagonists combined with non-drug therapy compared with cholinergic antagonist therapy alone for overactive bladder in adult women are unclear. Thus, we conducted a meta-analysis of randomized controlled trials to compare the therapeutic effects of cholinergic antagonists plus non-drug therapy (electrical stimulation and bladder training) with cholinergic antagonist therapy alone among female overactive bladder patients.
Methods
Pertinent studies were identified by searching PubMed, Web of Science, and the Chinese Biological Medicine databases to May 31, 2016. Study-specific standardized mean differences were combined using fixed- or random-effects models depending on whether significant heterogeneity was detected.
Results
Ten randomized controlled trials were identified. A total of 485 female overactive bladder patients were treated with the combined therapy and 497 were treated with the cholinergic antagonists alone. For the cholinergic antagonists combined with electrical stimulation treatment compared with cholinergic antagonist therapy alone, there were statistically significant reductions of average frequency of urination, incontinence, and urgency, with pooled standardized mean differences of −2.38, −1.32, and −0.87, respectively. There was also a statistically significant reduction of average frequency of urination (pooled standardized mean difference = − 0.30; 95 % confidence interval: −0.52 to −0.08) for the cholinergic antagonists combined with bladder training treatment compared with cholinergic antagonist therapy alone.
Conclusion
This study indicated that female overactive bladder patients with cholinergic antagonists combined with electrical stimulation or bladder training treatment may lower the average frequency of urination, incontinence, and urgency when compared with those who received isolated drug therapy.
Similar content being viewed by others
References
Tyagi S, Thomas CA, Hayashi Y, Chancellor MB. The overactive bladder: epidemiology and morbidity. Urol Clin North Am. 2006;33(4):433–8, vii. doi:10.1016/j.ucl.2006.06.002.
Stewart WF, Van Rooyen JB, Cundiff GW, Abrams P, Herzog AR, Corey R, et al. Prevalence and burden of overactive bladder in the United States. World K Urol. 2003;20(6):327–36. doi:10.1007/s00345-002-0301-4.
Tubaro A, Palleschi G. Overactive bladder: epidemiology and social impact. Curr Opin Obstet Gynecol. 2005;17(5):507–11.
Pagoria D, O’Connor RC, Guralnick ML. Antimuscarinic drugs: review of the cognitive impact when used to treat overactive bladder in elderly patients. Curr Urol Rep. 2011;12(5):351–7. doi:10.1007/s11934-011-0198-9.
Olivera CK, Meriwether K, El-Nashar S, Grimes CL, Grace Chen CC, Orejuela F, et al. Nonantimuscarinic treatment for overactive bladder: a systematic review. Am J Obstet Gynecol. 2016;. doi:10.1016/j.ajog.2016.01.156.
Arnold J, McLeod N, Thani-Gasalam R, Rashid P. Overactive bladder syndrome:management and treatment options. Aust Fam Phys. 2012;41(11):878–83.
Murphy AM, Krlin RM, Goldman HB. Treatment of overactive bladder: what is on the horizon? Int Urogynecol J. 2013;24(1):5–13. doi:10.1007/s00192-012-1860-6.
Kizilyel S, Karakeci A, Ozan T, Unus I, Barut O, Onur R. Role of percutaneous posterior tibial nerve stimulation either alone or combined with an anticholinergic agent in treating patients with overactive bladder. Turkish J Urol. 2015;41(4):208–14. doi:10.5152/tud.2015.94210.
Burgio KL. Update on behavioral and physical therapies for incontinence and overactive bladder: the role of pelvic floor muscle training. Curr Urol Rep. 2013;14(5):457–64. doi:10.1007/s11934-013-0358-1.
Tang H, Chen J, Wang Y, Yu T, Guo C, Liao X. Combination of sacral neuromodulation and tolterodine for treatment of idiopathic overactive bladder in women: a clinical trial. Urol J. 2014;11(4):1800–5.
Liu N, Liu CL, Feng C, Zhang JS, Qu Y. Clinical effects of tolterodine with pelvic floor electrical stimulation in the treatment of female OAB patients. Clin Med China. 2012;28:867–9.
Sancaktar M, Ceyhan ST, Akyol I, Muhcu M, Alanbay I, Mutlu Ercan C, et al. The outcome of adding peripheral neuromodulation (Stoller afferent neuro-stimulation) to anti-muscarinic therapy in women with severe overactive bladder. Gynecol Endocrinol. 2010;26(10):729–32. doi:10.3109/09513591003649815.
Zhang GT, Bao ZH, Zhang LD. Nerve stimulation combined with an anticholinergic agent in treating female patients with overactive bladder. J Pract Med. 2012;28(23):3990–2.
Burgio KL, Kraus SR, Borello-France D, Chai TC, Kenton K, Goode PS, et al. The effects of drug and behavior therapy on urgency and voiding frequency. Int Urogynecol J. 2010;21(6):711–9. doi:10.1007/s00192-010-1100-x.
Souto SC, Reis LO, Palma T, Palma P, Denardi F. Prospective and randomized comparison of electrical stimulation of the posterior tibial nerve versus oxybutynin versus their combination for treatment of women with overactive bladder syndrome. World J Urol. 2014;32(1):179–84. doi:10.1007/s00345-013-1112-5.
Zhong H, Xie LP, Zheng XY, Chen Y, Fang WL, Wang WG, et al. Efficacy of posterior tibial nerve stimulation in treating the female patients with overactive bladder. Zhonghua Mi Niao Wai Ke Za Zhi. 2014;35(9):695–9.
Wang JL, Wei D, Zhao Y, Wan B, Wang JY. Clinical efficacy of tolterodine tartate combined with transcutaneous electrical nerve stimulation in the treatment of elderly female patients with overactive bladder. Chin J Geriatr. 2012;31(2):147–50.
Burgio KL, Goode PS, Richter HE, Markland AD, Johnson TM 2nd, Redden DT. Combined behavioral and individualized drug therapy versus individualized drug therapy alone for urge urinary incontinence in women. J Urol. 2010;184(2):598–603. doi:10.1016/j.juro.2010.03.141.
Shamseer L, Moher D, Clarke M, Ghersi D, Liberati A, Petticrew M, et al. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation. BMJ. 2015;349:g7647. doi:10.1136/bmj.g7647.
Higgins JP, Altman DG, Gotzsche PC, Juni P, Moher D, Oxman AD, et al. The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials. BMJ. 2011;343:d5928. doi:10.1136/bmj.d5928.
Jadad AR. Randomised controlled trials. London: BMJ Publishing Group; 1998.
DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7(3):177–88.
Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21(11):1539–58. doi:10.1002/sim.1186.
Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315(7109):629–34.
Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics. 1994;50(4):1088–101.
Duval S, Tweedie R. A nonparametric “trim and fill” method of accounting for publication bias in meta-analysis. JASA. 2000;95:89–98.
Yu YF, Nichol MB, Yu AP, Ahn J. Persistence and adherence of medications for chronic overactive bladder/urinary incontinence in the california medicaid program. Value Health. 2005;8(4):495–505. doi:10.1111/j.1524-4733.2005.00041.x.
Hesch K. Agents for treatment of overactive bladder: a therapeutic class review. Proc (Bayl Univ Med Cent). 2007;20(3):307–14.
Griebling TL. Best treatment for overactive bladder if behavioral treatment and anticholinergics fail: sacral nerve stimulation. J Urol. 2011;185(6):2024–6. doi:10.1016/j.juro.2011.03.066.
Sherif H, Abdelwahab O. Posterior tibial nerve stimulation as treatment for the overactive bladder. Arab J Urol. 2013;11(2):131–5. doi:10.1016/j.aju.2013.04.007.
Kohli N, Patterson D. InterStim therapy: a contemporary approach to overactive bladder. Rev Obstet Gynecol. 2009;2(1):18–27.
Govier FE, Litwiller S, Nitti V, Kreder KJ Jr, Rosenblatt P. Percutaneous afferent neuromodulation for the refractory overactive bladder: results of a multicenter study. J Urol. 2001;165(4):1193–8.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Funding
This study was funded by the Shanghai Committee of Science and Technology Research Projects (No. 13441901202).
Conflict of interest
Yang Cao, Jianwei Lv, Chen Zhao, Jiayi Li, and Jing Leng declare that they have no conflicts of interest.
Rights and permissions
About this article
Cite this article
Cao, Y., Lv, J., Zhao, C. et al. Cholinergic Antagonists Combined with Electrical Stimulation or Bladder Training Treatments for Overactive Bladder in Female Adults: A Meta-Analysis of Randomized Controlled Trials. Clin Drug Investig 36, 801–808 (2016). https://doi.org/10.1007/s40261-016-0425-8
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40261-016-0425-8